Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1992 1
1993 5
1994 1
1995 1
1998 1
1999 3
2000 1
2001 3
2002 2
2003 2
2005 1
2006 1
2007 3
2008 2
2010 6
2011 6
2012 2
2013 3
2014 5
2015 4
2016 4
2017 3
2018 3
2019 12
2020 9
2021 7
2022 5
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.
Veyradier A, Boisseau P, Fressinaud E, Caron C, Ternisien C, Giraud M, Zawadzki C, Trossaert M, Itzhar-Baïkian N, Dreyfus M, d'Oiron R, Borel-Derlon A, Susen S, Bezieau S, Denis CV, Goudemand J; French Reference Center for von Willebrand disease. Veyradier A, et al. Among authors: ternisien c. Medicine (Baltimore). 2016 Mar;95(11):e3038. doi: 10.1097/MD.0000000000003038. Medicine (Baltimore). 2016. PMID: 26986123 Free PMC article.
C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.
Billoir P, Siguret V, Fron EM, Drouet L, Crassard I, Marlu R, Barbieux-Guillot M, Morange PE, Robinet E, Metzger C, Wolff V, André-Kerneis E, Klapczynski F, Martin-Bastenaire B, Pico F, Menard F, Ellie E, Freyburger G, Rouanet F, Allano HA, Godenèche G, Mourey G, Moulin T, Berruyer M, Derex L, Trichet C, Runavot G, Le Querrec A, Viader F, Cluet-Dennetiere S, Husein TT, Donnard M, Macian-Montoro F, Ternisien C, Guillon B, Laplanche S, Zuber M, Peltier JY, Tassan P, Roussel B, Canaple S, Scavazza E, Gaillard N, Triquenot Bagan A, Le Cam Duchez V. Billoir P, et al. Among authors: ternisien c. Res Pract Thromb Haemost. 2023 Mar 28;7(3):100130. doi: 10.1016/j.rpth.2023.100130. eCollection 2023 Mar. Res Pract Thromb Haemost. 2023. PMID: 37138790 Free PMC article.
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
Jeanpierre E, Pouplard C, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzallah I, Proulle V, Smahi M, Sobas F, Stepina N, Toulon P, Voisin S, Ternisien C, Nougier C; French Study Group on the Biology of Hemorrhagic Diseases (the BIMHO group). Jeanpierre E, et al. Among authors: ternisien c. Eur J Haematol. 2020 Aug;105(2):103-115. doi: 10.1111/ejh.13423. Epub 2020 May 27. Eur J Haematol. 2020. PMID: 32277501 Review.
[Factor IX assays in treated hemophilia B patients].
Pouplard C, Jeanpierre E, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzallah I, Proulle V, Smahi M, Sobas F, Ternisien C, Toulon P, Voisin S, Nougier C; groupe d’études de la biologie des maladies hémorragiques du Groupe français d’études de l’hémostase et la thrombose. Pouplard C, et al. Among authors: ternisien c. Ann Biol Clin (Paris). 2019 Feb 1;77(1):41-52. doi: 10.1684/abc.2019.1414. Ann Biol Clin (Paris). 2019. PMID: 30799297 Free article. Review. French.
[Factor VIII assays in treated hemophilia A patients].
Lasne D, Pouplard C, Nougier C, Eschwege V, Le Cam Duchez V, Proulle V, Smahi M, Harzallah I, Voisin S, Toulon P, Sobas F, Galinat H, Flaujac C, Ternisien C, Jeanpierre E; groupe d'études de la biologie des maladies hémorragiques du Groupe français d'études de l'hémostase et la thrombose. Lasne D, et al. Among authors: ternisien c. Ann Biol Clin (Paris). 2019 Feb 1;77(1):53-65. doi: 10.1684/abc.2019.1413. Ann Biol Clin (Paris). 2019. PMID: 30799298 Free article. Review. French.
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD.
Kizlik-Masson C, Peyron I, Gangnard S, Le Goff G, Lenoir SM, Damodaran S, Clavel M, Roullet S, Regnault V, Rauch A, Vincent F, Jeanpierre E, Dupont A, Ternisien C, Donnet T, Christophe OD, van Belle E, Denis CV, Casari C, Susen S, Lenting PJ. Kizlik-Masson C, et al. Among authors: ternisien c. Blood. 2023 Mar 23;141(12):1457-1468. doi: 10.1182/blood.2022017569. Blood. 2023. PMID: 36564031 Free article.
Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals).
Nougier C, Jeanpierre E, Ternisien C, Proulle V, Hezard N, Pouplard C, Lasne D; With contributions from the Working Group on Biology of Haemorrhagic Disorders (BIMHO, Under the Aegis of GFHT). Nougier C, et al. Among authors: ternisien c. Eur J Haematol. 2020 Dec;105(6):675-681. doi: 10.1111/ejh.13490. Epub 2020 Sep 16. Eur J Haematol. 2020. PMID: 32668090 Review.
The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study.
Trossaert M, Graveleau J, Thiercelin-Legrand MF, Sigaud M, Guerrero F, Neel A, Fouassier M, Sailler L, Chauveau D, Ternisien C, Huart A, Gillet B, Hamidou M, Bene MC, Voisin S. Trossaert M, et al. Among authors: ternisien c. Haemophilia. 2019 May;25(3):527-534. doi: 10.1111/hae.13752. Epub 2019 May 2. Haemophilia. 2019. PMID: 31050100
Prostate interventions in patients with mild haemophilia: Safe and feasible.
Mesnard B, Drillaud N, Sigaud M, Hakim G, Chelly S, Ternisien C, Fouassier M, Chelghaf I, De Vergie S, Perrouin Verbe MA, Rigaud J, David A, Trossaërt M, Branchereau J. Mesnard B, et al. Among authors: ternisien c. Haemophilia. 2021 Nov;27(6):e659-e666. doi: 10.1111/hae.14388. Epub 2021 Aug 3. Haemophilia. 2021. PMID: 34342928
92 results